Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms.
Bernardo Cacho-DíazKaren Salmerón-MorenoAlejandra Alvarez-AlvarezLaura Georgina Mendoza-OlivasAlberto Alvarado-MirandaCynthia Villarreal GarzaNancy Reynoso-NoverónMariana Chávez-MacGregorAntelmo Abelardo Meneses-GarcíaPublished in: Cancer (2020)
CNSm is not uncommon among patients with BC, particularly in those with neurologic symptoms who require neuro-oncology evaluation and are aged <50 years at the time of diagnosis, have HER2+ or triple-negative subtypes, have a poor Karnofsky performance status, and/or have ≥2 non-CNS metastases.